LivaNova (NASDAQ:LIVN) Hits New 52-Week High – Here’s What Happened

Shares of LivaNova PLC (NASDAQ:LIVN) hit a new 52-week high during trading on Tuesday . The company traded as high as $69.38 and last traded at $69.3250, with a volume of 908561 shares traded. The stock had previously closed at $68.35.

Analyst Ratings Changes

LIVN has been the topic of several analyst reports. Robert W. Baird set a $75.00 price target on shares of LivaNova in a research report on Tuesday, December 16th. Weiss Ratings reiterated a “sell (d+)” rating on shares of LivaNova in a report on Monday, December 29th. Mizuho upped their price objective on LivaNova from $70.00 to $72.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Stifel Nicolaus lifted their target price on LivaNova from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Finally, Wall Street Zen raised LivaNova from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 20th. Seven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $71.11.

LivaNova Trading Up 1.3%

The business has a fifty day moving average price of $64.14 and a 200-day moving average price of $58.59. The company has a quick ratio of 1.12, a current ratio of 1.33 and a debt-to-equity ratio of 0.30. The company has a market cap of $3.78 billion, a P/E ratio of -17.30 and a beta of 0.97.

Institutional Investors Weigh In On LivaNova

A number of institutional investors have recently modified their holdings of the business. Artisan Partners Limited Partnership grew its stake in shares of LivaNova by 94.5% in the third quarter. Artisan Partners Limited Partnership now owns 2,427,045 shares of the company’s stock valued at $127,129,000 after acquiring an additional 1,179,436 shares in the last quarter. Wellington Management Group LLP boosted its holdings in LivaNova by 83.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock valued at $122,858,000 after purchasing an additional 1,067,349 shares during the period. Invesco Ltd. grew its position in shares of LivaNova by 714.7% during the 2nd quarter. Invesco Ltd. now owns 1,028,713 shares of the company’s stock worth $46,313,000 after purchasing an additional 902,447 shares in the last quarter. Scopia Capital Management LP bought a new position in shares of LivaNova during the second quarter worth approximately $36,657,000. Finally, Millennium Management LLC raised its position in shares of LivaNova by 22.4% in the third quarter. Millennium Management LLC now owns 2,969,814 shares of the company’s stock valued at $155,559,000 after buying an additional 544,033 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.